Skip to content
Screener

Bruker BRKR Acquisitions

Acquisitions at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$17.74B
Danaher logo
DanaherDHR
$0-100%
WAT
Waters CorporationWAT
$0-100%
Agilent Technologies logo
Agilent TechnologiesA
$0
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
$2.24M
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$2.3B+754%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The source filing: Bruker’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211889
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net cash provided by operating activities71.265.0
Cash flows from investing activities:
Purchases of property, plant and equipment(24.2)(26.0)
Cash paid for acquisitions, net of cash acquired(16.0)(1.1)
Other investing activities, net0.51.0
Net cash used in investing activities(39.7)(26.1)
Cash flows from financing activities:
Repayments of revolving line of credit(167.9)

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's acquisitions?
Bruker (BRKR) reported acquisitions of $16M in Q1 2026.
How has Bruker's acquisitions changed year-over-year?
Bruker's acquisitions increased by 1354.5% year-over-year, from $1.1M to $16M.
What is the long-term trend for Bruker's acquisitions?
Over 4 years (2021 to 2025), Bruker's acquisitions has grown at a 3.3% compound annual growth rate (CAGR), from $65M to $73.9M.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Ask your AI about Bruker's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude